The substantial weight loss achieved with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual incretin agonists has transformed the management of obesity and cardiometabolic risk. However, the accompanying reduction in lean mass has raised concerns regarding potential sarcopenia and impaired physical functio...
Federica Moscucci, G. Tocci, G. Nardoianni et al.· High Blood Pressure & Cardio...· 0 citations
Background: Optimal blood pressure (BP) control remains elusive for millions of patients worldwide, often leading to resistant or secondary hypertension. Overactivation of the mineralocorticoid receptor (MR) drives this systemic pathology. While steroidal mineralocorticoid receptor antagonists (MRAs) are effective, the...
G. Marino, S. D. Di Fusco, E. Graziano et al.· Journal of Clinical Medicine· 0 citations
The AP-IJV max and the CSA-IJV max measurements showed excellent inter-observer reproducibility, suggesting the use of point-of-care ultrasound protocols for non-invasive volume assessment, particularly at the neck’s base or cricoid level.
N. Parenti, E. Guidetti, Davide Allegri et al.· Italian Journal of Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.